The chemicals categorized as CD32-A_Fc γ RIII Activators are not direct activators of this receptor. Instead, they are a diverse array of compounds that can indirectly influence the activity of CD32-A_Fc γ RIII by modulating key cellular pathways involved in its expression. Chemicals like Phorbol 12-myristate 13-acetate (PMA), Forskolin, Anisomycin, BAY 11-7082, Okadaic Acid, H-89, Lipopolysaccharides (LPS), U46619, Capsaicin, 3-isobutyl-1-methylxanthine (IBMX), and U0126 exert their effects by stimulating various signaling cascades. These pathways include the Protein Kinase C (PKC), PI3K/AKT, cAMP-PKA, JNK, NF-κB, MAPK, and calcium-related pathways. By activating these pathways, these compounds can potentially enhance the expression of FcγR, including CD32-A.
For instance, PMA, an activator of Protein Kinase C (PKC), stimulates the NF-κB pathway, potentially upregulating FcγR expression, including CD32-A. Similarly, EGF, a potent stimulator of the PI3K/AKT pathway, can enhance FcγR expression. Forskolin, an activator of adenylate cyclase, stimulates cAMP production and PKA activation, potentially leading to increased FcγR expression. In this way, while not interacting directly with the receptor, these compounds can potentially boost its expression or function by influencing the regulation of pathways involved in its expression. The variety of these compounds and their targets showcases the complex regulatory network governing CD32-A function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
An activator of Protein Kinase C (PKC) which stimulates the NF-κB pathway, thereby potentially upregulating FcγR expression, including CD32-A. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An activator of adenylate cyclase, which can stimulate cAMP production and PKA activation, leading to increased FcγR expression. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
A JNK pathway activator, potentially leading to increased FcγR expression. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An IKK inhibitor which paradoxically stimulates NF-κB pathway, thereby potentially increasing FcγR expression. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A PP2A inhibitor enhancing MAPK pathway, which is involved in FcγR expression. | ||||||
U-46619 | 56985-40-1 | sc-201242 sc-201242A | 1 mg 10 mg | $245.00 $1301.00 | 40 | |
A thromboxane A2 analog that can enhance MAPK pathway, potentially upregulating FcγR expression. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
An activator of TRPV1 which stimulates the NF-κB pathway, potentially leading to increased FcγR expression. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-specific PDE inhibitor which increases intracellular cAMP levels, potentially leading to increased FcγR expression. | ||||||